Asthma

Efforts are being made to ensure that health care providers deliver the right care at the right time.

Well-trained pharmacists can successfully screen patients for COPD in the community setting.

The FDA today approved Teva's albuterol sulfate inhalation powder (Proair RespiClick).

The FDA's advisory committee supports the approval of fluticasone furoate/vilanterol (Breo Ellipta) for the treatment of asthma in only adults.

The FDA is warning health care professionals and patients about OTC asthma products labeled as homeopathic remedies.

From optimizing inhaler technique in patients with chronic obstructive pulmonary disease, to catching red flags when dispensing controlled substances to patients with chronic pain, pharmacists can improve patient outcomes in an evolving treatment landscape.

With the wide selection of available inhalers, this article sheds light on factors that can influence COPD treatment success.

A pair of phase 3 studies recently demonstrated that Teva Pharmaceutical Industries' investigational treatment for moderate-to-severe asthma in patients with elevated blood eosinophils reduces asthma exacerbation rates by at least half.

A new start-up is looking to integrate smart sensors into current inhalers to increase adherence.

Student pharmacist-delivered education can have a positive impact on asthma knowledge among children.

Just 15% of employed adults with asthma consult with their health care professional on how work conditions might affect their disease.

By educating nurses, counseling physicians, and providing feedback on inhalation technique, pharmacists can reduce issues related to salbutamol treatment for asthma and bronchitis.

Symptoms include airflow obstruction, bronchial hyperresponsiveness, and airway inflammation.

See a new technique to treat severe asthma.

An examination of the pathophysiology of asthma.

A review of the pathology of asthma and COPD, including the role of the immune system, along with the mechanisms behind the hypercapnia and hypoxemia of COPD, and the blue bloater vs. pink puffer pseudodichotomy.

Rhinovirus infection tends to aggravate other conditions in the elderly.

Patients with bronchial asthma or chronic obstructive pulmonary disease fare best with metered dose inhalers that have spacer devices.

A discovery at a pharmacy led to a jarring investigation into the past use of cigarettes as a means of treating asthma.

The majority of patients who require inhalers for asthma or epinephrine autoinjectors for allergic disease for do not use the devices properly.

Researchers from the Karolinska Institutet have dismissed the idea of a causal link between antibiotic use in early life and childhood asthma.

In a recent phase 2b study, patients with asthma reported reduced exacerbations and improved lung function after receiving dupilumab, an investigational therapy from Sanofi-Aventis and Regeneron Pharmaceuticals Inc.